Woodline Partners’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,767,719
| Closed | -$12.6M | – | 1051 |
|
|
2025
Q1 | $12.6M | Buy |
+2,767,719
| New | +$12.6M | 0.08% | 319 |
|
|
2024
Q2 | – | Sell |
-521,112
| Closed | -$6.92M | – | 675 |
|
|
2024
Q1 | $6.92M | Buy |
521,112
+23
| +0% | +$305 | 0.06% | 323 |
|
|
2023
Q4 | $7.26M | Sell |
521,089
-171
| -0% | -$2.38K | 0.08% | 264 |
|
|
2023
Q3 | $6.91M | Buy |
521,260
+126,839
| +32% | +$1.68M | 0.08% | 267 |
|
|
2023
Q2 | $7.4M | Buy |
394,421
+7,955
| +2% | +$149K | 0.09% | 243 |
|
|
2023
Q1 | $5.57M | Buy |
386,466
+10,189
| +3% | +$147K | 0.08% | 277 |
|
|
2022
Q4 | $7.28M | Buy |
376,277
+1,282
| +0.3% | +$24.8K | 0.1% | 261 |
|
|
2022
Q3 | $12.9M | Buy |
374,995
+224,995
| +150% | +$7.73M | 0.18% | 164 |
|
|
2022
Q2 | $2.29M | Hold |
150,000
| – | – | 0.04% | 405 |
|
|
2022
Q1 | $3.42M | Sell |
150,000
-26,027
| -15% | -$594K | 0.06% | 294 |
|
|
2021
Q4 | $6.49M | Sell |
176,027
-26,473
| -13% | -$976K | 0.09% | 252 |
|
|
2021
Q3 | $9.52M | Sell |
202,500
-4,421
| -2% | -$208K | 0.16% | 168 |
|
|
2021
Q2 | $12.5M | Buy |
+206,921
| New | +$12.5M | 0.23% | 113 |
|